首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:American journal of clinical oncology-cancer clinical trials

缩写:AM J CLIN ONCOL-CANC

ISSN:0277-3732

e-ISSN:1537-453X

IF/分区:1.8/Q4

文章目录 更多期刊信息

共收录本刊相关文章索引2830
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Cody Chou,Coby Y Garcia,Shriya K Garg et al. Cody Chou et al.
Objectives: Gastric cancer affects over 30,000 Americans annually and has a 5-year survival rate of roughly 40%. Palliative-intent interventions are critical for symptom relief and quality of life, yet access remains ineq...
Congming Bu,Jing Wang,Feng Gu et al. Congming Bu et al.
Objectives: This study explored the effectiveness of family-centered early palliative care on emotional well-being and quality of life for Chinese advanced cancer (AC) and their caregivers (CGs). ...
Gongzhen Liu,Chang Xu,Luyijie Chai et al. Gongzhen Liu et al.
Objective: Conventional neoadjuvant chemotherapy yields limited benefits for locally advanced head and neck squamous cell carcinoma (LA-SCCHN) patients. Emerging neoadjuvant immunochemotherapy (ICT) holds potential; howev...
Gizem C Uçar,Sevgisun Kapucu,Ayşe A Dönmez et al. Gizem C Uçar et al.
Objectives: Lymphedema associated with breast cancer is a chronic condition that negatively affects women's physical functioning, psychosocial well-being, and quality of life. Although self-management education is a funda...
Sarah Feldkamp,Claire Niewiara,Bailey Nelson et al. Sarah Feldkamp et al.
Objectives: To evaluate the hepatotoxicity and clinical outcomes following external beam radiation therapy (EBRT) in patients with hepatocellular carcinoma (HCC) previously treated with Yttrium-90 radioembolization (Y-90)...
Ibraheem Altamimi,Faisal A Al-Harbi,Abdelmalek Ammar AlHaj Abdelghani et al. Ibraheem Altamimi et al.
Objectives: Malignant melanoma, although less frequent than other skin cancers, accounts for most skin cancer deaths due to its aggressive and metastatic nature. Despite therapeutic progress, its global distribution remai...
Umar Akram,Zain A Nadeem,Obaid Ur Rehman et al. Umar Akram et al.
Objectives: The role of camrelizumab in combination therapy for triple-negative breast cancer (TNBC) is unclear. This systematic review and meta-analysis aimed to evaluate the efficacy and safety of camrelizumab combinati...
Zaheer Qureshi,Abdur Jamil,Kazi Samsuddoha et al. Zaheer Qureshi et al.
Objectives: Targeted immunotherapies have significantly revolutionized the treatment of hematologic malignancies. Among the most promising immunotherapies are bispecific T-cell engagers (BiTEs) and immune checkpoint inhib...
Zaheer Qureshi,Abdur Jamil,Neehal Wali et al. Zaheer Qureshi et al.
Background: Currently, cyclin-dependent kinases 4 and 6 (CDK4/6) inhibitors combined with hormone therapy are the standard treatment for patients with hormone receptor-positive/human epidermal growth factor receptor 2-neg...
Zaheer Qureshi,Abdur Jamil,Kazi Samsuddoha et al. Zaheer Qureshi et al.
Objectives: The vascular endothelial growth factor (VEGF) pathway plays a crucial part in tumor angiogenesis by enhancing the creation of new blood vessels that supply oxygen. Breast cancer cells with overexpressed human ...